Toshida Katsuya, Itoh Shinji, Iseda Norifumi, Tanaka Shugo, Nakazono Kensuke, Tomiyama Takahiro, Yoshiya Shohei, Toshima Takeo, Harada Noboru, Kohashi Kenichi, Taniguchi Koji, Oda Yoshinao, Yoshizumi Tomoharu
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Integrative Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Liver Cancer. 2024 Aug 12;14(1):36-57. doi: 10.1159/000540180. eCollection 2025 Mar.
-induced glycolysis and apoptosis regulator (TIGAR) is a p53 target protein that has critical roles in glycolysis and redox balance. The reports about the effect of TIGAR on prognosis and its biological role in hepatocellular carcinoma (HCC) are limited.
A total of 386 patients with HCC who had undergone hepatic resection were enrolled. Immunohistochemical staining for TIGAR was performed. Additionally, the regulation of malignant activity and ferroptosis by TIGAR was investigated in vitro.
Patients were divided into TIGAR-positive ( = 80, 20.7%) and -negative ( = 306, 79.3%) groups. TIGAR positivity was significantly correlated with lower albumin, higher α-fetoprotein/ -gamma-carboxyprothrombin, larger tumor size/number of tumors, and greater proportions of BCLC staging C/single nodular type/poor differentiation/microscopic vascular invasion/microscopic intrahepatic metastasis. In multivariate analysis, TIGAR positivity was an independent prognostic factor ( < 0.0001). In addition, TIGAR positivity was significantly associated with a smaller number of cluster of differentiation (CD) 8-positive T cells ( = 0.0450), larger number of CD68-positive macrophages ( = 0.0058), larger number of programmed death-ligand 1-positive cases ( = 0.0002), and larger number of vessels that encapsulate tumor cluster-positive cases ( = 0.0004). In vitro, knockdown decreased cell motility and induced ferroptosis. knockdown inhibited the phosphorylation of adenosine monophosphate-activated protein kinase and acetyl-CoA carboxylase. Ferroptosis induced by knockdown was inhibited by liproxstatin and baicalein treatment. The combination of knockdown and lenvatinib further induced ferroptosis.
High expression of TIGAR impacted the clinical outcome of HCC patients and TIGAR was associated not only with tumor microenvironment but also with resistance to ferroptosis.
-诱导的糖酵解和凋亡调节因子(TIGAR)是一种p53靶蛋白,在糖酵解和氧化还原平衡中起关键作用。关于TIGAR对预后的影响及其在肝细胞癌(HCC)中的生物学作用的报道有限。
共纳入386例接受肝切除术的HCC患者。进行TIGAR的免疫组织化学染色。此外,在体外研究了TIGAR对恶性活性和铁死亡的调节作用。
患者分为TIGAR阳性(=80,20.7%)和阴性(=306,79.3%)组。TIGAR阳性与较低的白蛋白、较高的甲胎蛋白/-γ-羧基凝血酶原、较大的肿瘤大小/肿瘤数量以及较高比例的BCLC分期C/单结节型/低分化/微血管侵犯/微小肝内转移显著相关。在多变量分析中,TIGAR阳性是一个独立的预后因素(<0.0001)。此外,TIGAR阳性与较少的分化簇(CD)8阳性T细胞数量(=0.0450)、较多的CD68阳性巨噬细胞数量(=0.0058)、较多的程序性死亡配体1阳性病例数量(=0.0002)以及较多的包绕肿瘤簇阳性病例的血管数量(=0.0004)显著相关。在体外,敲低TIGAR可降低细胞运动性并诱导铁死亡。敲低TIGAR可抑制腺苷单磷酸激活蛋白激酶和乙酰辅酶A羧化酶的磷酸化。敲低TIGAR诱导的铁死亡可被liproxstatin和黄芩素处理抑制。敲低TIGAR与乐伐替尼联合使用可进一步诱导铁死亡。
TIGAR的高表达影响HCC患者的临床结局,TIGAR不仅与肿瘤微环境相关,还与铁死亡抗性相关。